Choom (CSE:CHOO,OTCQB:CHOOF) announced Wednesday (July 17) that pursuant a convertible debenture issued to Choom by Coastal Green Holdings, Choom will acquire a 19.9% equity interest in the BC-based cannabis retailer.
As quoted in the press release:
Choom’s investment includes various rights, including the right in certain circumstances to acquire 100% of Coastal Green, subject to regulatory restrictions on the number of cannabis retailers Choom may own over time. This investment provides another avenue for Choom to expand its growing cannabis retail footprint in British Columbia and Alberta. Coastal Green has submitted its application to the British Columbia Liquor and Cannabis Regulation Branch (“LCRB”) to become an approved retailer with the intention of opening 8 retail stores mostly localized on the islands off the west coast of British Columbia. Choom will assist Coastal Green by providing support with its cannabis retail operational expertise and store development.
“Coastal Green makes a very welcomed addition to our portfolio of brands and our network of cannabis retail locations in Canada.” states Chris Bogart, President & CEO of Choom. “The key driver for this investment was finding an innovative way to maximize our footprint in BC while also gaining additional revenue streams to further grow shareholder value. With the Coastal Green concept, consumers can expect the same warm and welcoming experience with knowledgeable staff they’ve come to know in our Choom locations.”
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/